Daniel Martin Klotz

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Patient Reported

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Clinical chemistry and laboratory medicine

Molecular oncology

Archives of gynecology and obstetrics

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Martin Klotz, Theresa Link, Pauline Wimberger, Jan Dominik Kuhlmann
A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin). Clinical chemistry and laboratory medicine (2023)
Daniel Martin Klotz, Theresa Link, Maren Goeckenjan, Pauline Wimberger, Jan Dominik Kuhlmann
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker. Molecular oncology 15 (9) (2021)
Daniel Martin Klotz, Theresa Link, Pauline Wimberger, Jan Dominik Kuhlmann
Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer. Molecular oncology 15 (12) (2021)
Daniel Martin Klotz, Theresa Link, Maren Goeckenjan, Pauline Wimberger, Anna R Poetsch, Nikolai Jaschke, Lorenz C Hofbauer, Andy Göbel, Tilman D Rachner, Jan Dominik Kuhlmann
Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients. Clinical chemistry and laboratory medicine 60 (1) (2021)
Daniel Martin Klotz, Pauline Wimberger
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies? Archives of gynecology and obstetrics 302 (5) (2020)